CordenPharma extends deal with Moderna to supply lipids for COVID-19 vaccine
Published
Pharmaceutical company CordenPharma has extended its agreement with Moderna Inc to supply large volumes of lipids used to produce Moderna's COVID-19 vaccine candidate.
Full Article